Navigation Links
Neurosurgery publishes findings of 3 important studies in June issue
Date:6/19/2013

Philadelphia, Pa. (June 19, 2013) The results of three important studies have been published in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

One study indicates that continuous "machine learning" using artificial neural networks (ANNs) may improve the ability to predict survival in patients with advanced brain cancers. Another study in the June Neurosurgery supports increased use of stereotactic biopsy for obtaining samples of brainstem tumors; while another calls for medical professionals and specialty societies to play an increased role in evaluating "off label" uses of medications.

Artificial Neural Networks Predict Brain Cancer Prognosis

Dr. Matthew Ewend of University of North Carolina and colleagues evaluated the use of ANNs to predict the chances of survival for patients with brain cancer. Based on the biological functioning of brain cells, ANNs are computer programs designed "to learn patterns within a data set and then apply that learning for recognition and prediction."

The researchers performed a pilot study of ANNs using data on patients treated for advanced brain cancer at several hospitals. The results showed that ANNs beat standard prediction models for predicting patient survival. "Pooled voting" of five ANNs correctly predicted the risk of death within one year in 84 percent of patients, compared to 78 percent with a single ANN and 74 percent using standard statistical techniques.

The predictive power of ANNs would likely increase over time, providing a "facile and powerful means or predicting survival" in patients with brain cancers or other conditions. The researchers conclude, "With the explosion in clinical data over the past few years.we anticipate a growing need for modern machine learning techniques such as ANNs to properly make use of the information at our disposal and realize its full benefit for clinical care."

New Proposal for Evaluating 'Off Label' Uses of Medications

An improved process for evaluating "off label" use of drugsusing medications for purposes other than those for which they were approvedis described by Donlin Long, MD, PhD, of Johns Hopkins School of Medicine and Clark Watts, MD, JD, of University of Texas School of Law. They cite the example of bone morphogenetic protein-2 (BMP-2), a product approved to promote bone growth in one specific type of spinal fusion surgery.

After approval, surgeons started using BMP-2 for various other types of spinal surgeryleading to complications in some cases. The authors believe that problems resulting from "uncontrolled" off-label use have had a chilling effect, leading to missed opportunities to develop effective uses of BMP-2.

In the proposed approach, medical specialty societies such as the Congress of Neurological Surgeons would play a leading role in setting parameters for off-label use of new products, and in systematically gathering evidence of effectiveness. Drs. Long and Watts write, "Our goal is to challenge our professional societies to take a leadership role in the study of valid uses of new drugs and devices in a cooperative, constructive relationship with government regulators and industry."

Stereotactic Biopsy for Brainstem Tumors

Dr. Philipp Kickingereder of University Hospital of Cologne and colleagues present a review of research evidence on stereotactic biopsyusing triangulation techniques to precisely localize tumorsto obtain samples of uncommon brainstem cancers. While stereotactic biopsy is not a new technique, surgeons may hesitate to use it for brainstem tumors because of the perceived risks of the procedure.

But the available data show a diagnostic success rate of 96 percent, with a relatively low complication rates. Dr. Kickingereder and coauthors conclude that stereotactic biopsy is a safe and valuable procedure that provides samples for simultaneous tissue and genetic analysiswhich may allow more individualized treatment. They recommend its use in all adult patients with brainstem cancers, as well as in certain groups of children.


'/>"/>

Contact: Connie Hughes
connie.huges@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. No July phenomenon for neurosurgery patients, reports Neurosurgery
2. Virtual reality simulator helps teach surgery for brain cancer, reports Neurosurgery
3. Limiting neurosurgery residents work hours hasnt decreased complication rates
4. Virtual reality and robotics in neurosurgery -- promise and challenges
5. No need for routine repeated CT scans after mild head trauma, reports neurosurgery
6. New biomarker may help in detecting gliomas, reports Neurosurgery
7. SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples
8. Moffitt researcher publishes book on nutritional management of cancer treatment effects
9. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
10. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
11. ASTRO publishes Safety is No Accident: A Framework for Quality Radiation Oncology and Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a comprehensive ... NC. Dr. Brian Seese leads the practice as a skilled and highly credentialed dentist ... Smiles by Seese serves patients of all ages with excellence in general, restorative, and ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... allow for the electronic prescribing of controlled and non-controlled substances plus the ability ... of pharmacies in the United States now accept electronic prescriptions, according to the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering ... Francis' goals for each and every seminar, session and class she offers. ... five different brainwave tools which help energize creativity, focus mental functions, enhance athletic ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access ... & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) ... widely used electronic patient signatures solution in healthcare . , Since it ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica ... focusing on all facets of clinical trial planning and management. Pharmica discussed the ... and more. In addition, attendees stopping by Pharmica’s booth were able to demo ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  BioDigital, Inc., creators of the ... their 3D body mapping technology with eClinicalWorks, a ... integration will be used to capture and present ... the human body. BioDigital pilots show using a ... also increasing the precision of clinical annotations compared ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
Breaking Medicine Technology: